Insider trades
Michael Thomas Heffernan, Director of enGene Therapeutics ENGN, has filed 17 transactions, none an open-market purchase or sale. The latest trade was on 06/16.
Michael Thomas Heffernan
Director
- Company
- enGene Therapeutics ENGN
- First filing
- 23/05/04
- Trades
- 17 trades
- Buys / sales
- 0 / 0
- 12-month net buying
- No record
- Last trade
- 06/16
Trading activity
Transactions
No filed transactions.